Quantification of intrahepatic non-uniform distributions for assessing impaired function of liver using Tcm-DTPA-galactosyl serum albumin liver SPECT scintigraphy

Nuclear Medicine Communications

Volumn 22, Issue 5, 2001, Pages 505-512

  Mitomo, O ^a   Tsunoda, T ^b   Nakamura, K ^b   Kuwabara, H ^b  

^a Kagawa University   (Japan)

^b National Numata Hospital   (Japan)

Author keywords

99mTc galactosyl serum albumin (99mTc GSA); Functional hepatic volume; Liver scintigraphy; Nonuniform distribution; SPECT

Indexed keywords

ALBUMIN PENTETATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISTRIBUTION; FEMALE; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER METASTASIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOLUMETRY;

HEPATITIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; RADIOPHARMACEUTICALS; REFERENCE VALUES; REGRESSION ANALYSIS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035024395     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200105000-00007     Document Type: Article

References (32)

1. Ashwell G, Steer CJ. Hepatic recognition and catabolism of serum glycoproteins. JAMA 1981; 246: 2358-2364.
2. Stockert RJ, Morell AG. Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes. Hepatology 1983; 3: 750-757.
3. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246: 1461-1467.
4. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 1974; 41: 99-128.
5. Stowell CP, Lee YC. The binding of D-glucosyl-neoglycoproteins to the hepatic asialoglycoprotein receptor. J Biol Chem 1978; 253: 6107-6110.
6. 99mTc-GSA, a new agent for functional imaging of the liver. Jpn J Nucl Med 1992; 29: 85-95.
7. 99mTc-GSA, a new agent for functional imaging of the liver. Jpn J Nucl Med 1992; 29: 159-181.
8. Koizumi K, Uchiyama G, Arai T, et al. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters. Ann Nucl Med 1992; 6: 83-87.
9. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989; 19: 98-129.
10. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage. Am J Gastroenterol 1992; 87: 865-870.
11. Ishak KG, Markin RS. Liver. In: Damjanov I, Linder J, eds. Anderson's pathology. St. Louis: Mosby, 1990: 1779-1858.
12. Mitomo O, Aoki S, Tsunoda T, Yamaguchi M, Kuwabara H. Quantitative analysis of nonuniform distributions in lung perfusion scintigraphy. J Nucl Med 1998; 39: 1630-1635.
13. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m- galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology 1984; 151: 191-196.
14. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m- galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding. J Nucl Med 1984; 25: 779-787.
15. Vera DR, Stadalnik RC, Krohn KA. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med 1985; 26: 1157-1167.
16. Eckelman WC, Reba RC, Gibson RE, et al. Receptor-binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med 1979; 20: 350-375.
17. Marshall JS, Green AM, Pensky J, et al. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Invest 1974; 54: 555-562.
18. Sawamura T, Nakada S, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984; 87: 1217-1221.
19. Sawamura T, Kawasato S, Tsuda M, Naitoh Y, Shiozaki Y, Sameshima Y. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma. Gastroenterol Jpn 1985; 20: 201-208.
20. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 1991; 32: 2233-2240.
21. 99mTc-GSA, a new agent for functional imaging of the liver. Jpn J Nucl Med 1991; 28: 1321-1331.
22. Rubin E, Farber JL. The liver and biliary tract. In: Rubin E, Farber JL, eds. Pathology. Philadelphia: Lippincott, 1988: 722-807.
23. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
24. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
25. Okuda K. Epidemiology of primary liver cancer. In: Tobe T, Kameda H, Okudaira M, et al., eds. Primary liver cancer in Japan. Tokyo: Springer-Verlag, 1992: 3-15.
26. Okuda K, The Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980; 45: 2663-2669.
27. Kudo M, Todo A, Ikekubo K, et al. Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 1991; 26: 734-741.
28. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium-99m galactosyl human serum albumin. Hepatology 1993; 17: 814-819.
29. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of 99mTc-galactosyl-neoglycoalbumin. J Nucl Med 1991; 32: 1169-1176.
30. Vera DR, Scheibe PO, Krohn KA, Trudeau WL, Stadalnik RC. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng 1992; 39: 356-367.
31. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 1994; 20: 917-923.
32. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med 1991; 32: 1177-1182.